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Abstract 
The main purpose of the study is to investigate the change in Fasting Blood Sugar (FBS) level over time and the 
effect of some plausible factors on this change for Type-2-Diabetes (T2D) patients on treatment. Retrospective 
data from the Ketu-South Municipal Hospital, Diabetes Unit, in Ghana in which patients’ FBS level and 
demographic data were monitored regularly every three months was used for the study. Profile analysis was used 
to study the pattern of change in the FBS level.  
The MANOVA test of parallelism showed at 5% significance level that religion was not parallel because there 
was significant differential in the pattern of change of the FBS level. The other covariates: gender, marital status, 
drug and education did not significantly differ at the 5% significance level and hence their profiles were tested 
for parallelism. The parallelism tests revealed that they were parallel and equal but deviated from flatness  
The analysis revealed that although the treatment remained effective, the trend of FBS level over time was cubic, 
indicating that initially the FBS level usually increases and then eventually declines with time, only to rise again. 
The cubic profile trend obtained was  = 0.089	
 − 1.469	 + 6.793t  with a quadratic rate of change in 
FBS level given as 
  

  = 0.267	 − 2.938	 + 6.793  
Where t = 0,1,2,…,	 for intervals of 0, 3, 6, ….., n months. 
The diagnostic statistical tests on the trend confirmed that the trend model was adequate for estimating FBS level 
of diabetic patients on treatment.  
From this research, we are therefore suggesting that in addition to using the drugs to manage the diabetes, the use 
of the rate of change in FBS level function should be promoted to strengthen the management of diabetic 
patients on treatment through reliable monitoring and evaluation. We further suggest for more research to test for 
the significant covariates for the type 2diabetes to fit mixed effect regression model (s) for monitoring type 2 
diabetes.  
Keywords: FBS level, Type 2 diabetes, Profile analysis, trend model 
 
1. Introduction 
Diabetes mellitus is a disease characterized by the inability to regulate blood glucose levels, resulting in 
chronically increased blood glucose levels, or hyperglycaemia'(Saltiel et al., 2001). Type 2 diabetes mellitus 
results from an imbalance between insulin sensitivity and insulin secretion. Type 2 diabetes is the most common 
form of diabetes and comprises 90% of people with diabetes around the world (WHO, Fact Sheet No.312). The 
world prevalence of diabetes in 2010 among adults aged 20-79 years is estimated to 6.4%, affecting 285 million 
adults (Shaw et al., 2010). Each year more than 396 million people worldwide die from diabetes and its 
complications (International Diabetes Federation, 2009).  
 Both longitudinal and cross-sectional studies have demonstrated that the earliest detectable abnormality in type 
2 diabetes is an impairment of the body's ability to respond to insulin. Type 2 diabetes is now increasingly being 
diagnosed in adult children and adolescents. Researches revealed that men are biologically more susceptible to 
diabetes than women. Many studies have elaborated the associations between several risk factors and the risk of 
type 2 diabetes. Body mass index (BMI), lipids, hypertension, smoking, physical inactivity, low education, 
dietary patterns, family history, and recently also specific genes are the most frequently documented risk factors 
for type 2 diabetes (Lyssenko et al., 2008). This means that the health risks for diabetes are multifactorial with a 
cumulative effect. 
A guiding principle in the treatment of type 2 diabetic patients has been the recommendation to lose weight 
(American Diabetes Association. 2004). This is because the health benefits of weight loss have long been 
recognized (Newburgh, 1942). Redmon et al., 2005, reported on the 2-year outcome of weight loss therapies in 
type 2 diabetic patients that the end result was a weight loss of 4.6 kg sustained over 2 years, which led to a 
decrease of HbA1c of 0.5% indicating improvement in the condition. Models are being developed to study the 
type 2 diabetes. Spangler et al., (2013) modeled the correlation between diabetes prevalence and subsequent 
cancer mortality in North Carolina counties and Powers B. J., (2008) also modeled the effect of a hypertension 
self-management Intervention on Diabetes and Cholesterol Control.  
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Ghana seems to be epidemiologically limited because epidemiological data on the prevalence of diabetes in 
Ghana is scanty. However, evidence suggests that diabetes is on the increase. In the 1950s, the prevalence of 
diabetes among an outpatient urban population in Accra was estimated at less than 0.5% (Dodu, 1958). The 
impression was therefore created among policy makers that diabetes is rare in Ghana. However, a recent study 
(Amoah et al., 2002) reported a high prevalence rate of 6.3%.  A study on the key predisposing factors of 
diabetes which assessed the prevalence and sociodemographic aspects of overweight and obesity among 
residents from rural and urban Accra reported an overall crude prevalence of 23.4% and 14.1%, respectively 
(Amoah, 2003).  
Experts in the medical field work tirelessly to come out with the requisite panacea to help alleviate if not cure the 
disease. Health practitioners and policy makers find it difficult to predict the FBS level of the diabetic patient, 
which is very fundamental to the healthcare process in the administration of the drugs. This has triggered 
researchers to direct their attention to modeling diabetes but the first approach to this is the localised profile 
analysis using longitudinal study. This study therefore aims to investigate the profile of type 2 diabetes and to 
determine the pattern of change in FBS level in the diabetic patients on treatment over period of times by 
conducting a retrospective longitudinal study at Ketu South Municipality of Ghana. 
 
2. Materials and Methods  
2.1 Data Used 
Secondary data from the diabetes unit of Ketu-South Municipal Hospital was used. In the study, 101 individuals 
diagnosed of type 2 diabetes (T2D) and put on treatment were followed retrospectively from January 2012 to 
December 2013. Eligibility criterion was used to recruit eighty (80) patients into the study. The datasets 
collected on the diabetic patients include the vital statistics: Fasting Blood Sugar (FBS) level, body weight, 
blood pressure, drug regimen, and some demographic data such as gender, marital status, level of education and 
religious affiliation.  
2.2 Profile Analysis Approach 
Generally there are two different types of data that are measured overtime: time series, which takes many 
measurements on a (usually) small set of individuals, and longitudinal data, which takes a small number of 
measurements on a (usually) large number of individuals. This research used longitudinal study in which there is 
a small number of time points at which the individuals give responses, but in this case there is a large amount of 
data measured at any given time point. 
Profile analysis was performed on the FBS level of the patients and the covariates gender, marital status, 
educational level, duration of treatment (time), and drug regimen were considered. The duration of treatment was 
in intervals of 3 months, with the initial FBS level taken at time t0 such that the time t = 0, 1, 2, 3 and so on 
represents 0, 3, 6, 9 months  respectively.  
This approach is to observe the pattern of the average change in FBS level over time. The variables used for the 
profile plots were gender, marital status, educational level, religious affiliation and drug regimen. Profiles were 
constructed for the means of FBS levels versus the time points for the various groups.  
2.2.1 Shapiro-Wilks Test for Normality 
This test is the significance level for testing normality. Given a set of observations  ̅, ̅, ̅
, … , ̅  sorted 
in either descending or ascending order, the test statistics of Shapiro and Wilks, W is defined as: 
! = ∑ #$%$&$'(
)
∑ %$*%̅&$'(
)                                             (1)                 +ℎ-.-	̅ = 1/1∑ 2	23 , is the samples 
mean and 42 for 5 = 1, 2, 3, … , 1 are a set of “weight” whose values depend only on the sample size n 
2.2.2 ARCH-LM Test for Conditional heteroscedasticity  
The issue of conditional heteroscedasticity is one of the key problems that a researcher is likely to encounter 
when fitting models. This happens when the variance of the residuals is not constant. To ensure that the fitted 
model is adequate, the assumption of constant variance must be achieved. The ARCH-LM test proposed by 
Engle (1982) was used to test for the presence of conditional heteroscedasticity in the model residuals. The test 
hypothesis is as follows; 
H0: There is no heteroscedasticity in the model residuals 
H1: There is heteroscedasticity in the model residuals 
The test statistic is 
          
2nRLM =
                                                                 (2) 
where n is the number of observations and 6  is the coefficient of determination of the auxiliary residual 
regression. 
- = 78 + 7-* + 7-* +. . . +79-*9 + : 																									3 
where - is the residual. The null hypothesis is rejected when the p-value is less than the level of significance and 
is concluded that there is heteroscedasticity. 
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2.2.3 The Profile trend  
Multivariate Analysis of variance (MANOVA) was performed to fit the profile trend and to complement and 
confirm the profile plot of test of parallelism. Assuming parallelism, the fitted pattern for the FBS level was fully 
tested for the parallelism, equality and flatness for each covariate.  
 
3. Results  
This chapter covers the following findings: Descriptive Statistics of FBS level of patients on treatment, 
preliminary analysis, profiles of the FBS level with respect to the covariates. 
3.1 Descriptive Statistics 
The descriptive statistics of the 80 diabetic patients was presented in Table 1. The mean, median, standard 
deviation, minimum, and maximum scores of FBS level at each measurement point for the 80 diabetic patients 
were stratified by Gender, Education, Marital status, Religious affiliation and drug.  
The age of the patients ranges from 33 to 84 years. The mean and median ages were 58 and 53 respectively. The 
females were twice as the males, constituting 67.5% and 32.5% respectively but the mean change in FBS level 
for males was 7.86196 mmol/l whiles that of the females was 7.52880 mmol/l.  
Those with primary education had the highest mean FBS level of 8.20222mmol/l and the least of 7.33888mmol/l 
is scored by patients with senior high school educational level.  
With regard to marital status, the widowed patients had the best mean FBS level (7.38888mmol/l) and the 
patients who were single had the worse mean FBS level of 8.93333mmol/l 
Throughout the treatment, three types of drugs were used.  Averagely, patients on glimepiride had the best FBS 
level (7.52936mmol/l) and followed by glibenclamide (7.59540mmol/l) and then metformin (7.71051mmol/l). 
3.2 Profile Analysis 
3.2.1 Profile plot of FBS by Gender 
The pattern of change in FBS level over the period of observation for gender showed that both sexes initially 
increased sharply and at t1, that of the female declined whiles male remained constant until t2 and after that, both 
seemed to be changing in almost the same pattern but with the male almost leading (Fig. 1). 
3.2.2 Profile Plot of FBS Level by Educational Level 
The profile plot of the change in FBS level by educational level over time (Fig. 2) showed variations. The FBS 
level of patients in all the categories rose initially and all except Senior high, fall at t1 and then all of them, 
except patients with junior high education, started fluctuating. The change in FBS level of Patients with primary 
education is ever leading. 
3.2.3. Profile Plot of FBS level by Marital status 
Figure 3 indicates the average change in FBS level in the marital group. The single category decreased rapidly 
from time point t0 to t2 and then seemed to assume approximately the same pattern as widow(er), however, 
others increased initially. Furthermore, married and divorced patients followed approximately similar pattern, 
commitedly declined. However, the FBS level of the separated patients fluctuates as it moves over the time 
points. 
3.2.4 Profile Plot of FBS level by Drug 
From Fig. 4, the average change in FBS level in the drug regimen over time is approximately the same for 
Metformin and Glimepiride profiles. However, after all of them rose from t0 to t1, Glibenclamide profile slightly 
differed in the pattern as it flattens from t1 to t2 and then falls rapidly and fluctuates. Averagely, from the profile, 
even though, is very competitive, metformin seemed to perform worse than glimepiride. 
3.2.5 Profile plot of FBS level by Religion 
Figure 5 indicates that the average change in FBS level in the religious group is approximately similar for all the 
religious groupings except “Others” which continue to increase until t2 after the rest declined from t1. 
Christians, however, leads most of the times. 
3.2.6 The Pattern of FBS Level with time  
The general pattern of FBS level profile over the period of treatment produced a cubic function (Fig. 6) depicting 
that the change in FBS level increases over time and then fall, only  to rise again.This is confirmed by the cubic 
model having the highest 6 value (6 value = 0.9100) among the eleven trends tested, accounting for 91% of 
the variability in the data (Table 2). Thus the cubic trend model 
  = 0.089	
 − 1.469	 + 6.793t 
is selected as the best trend. 
3.2.7 Significant test for the cubic pattern 
Analysis of Variance (ANOVA) table 3 shows that the regression analysis on time for the cubic trend model is 
statistically significant (p-value = 0.000). 
3.2.8  The Cubic Trend Model Diagnoses 
The adequacy of the model was tested with Shapiro-wilk and ARC-LM tests (Table 4). The Shapiro-wilks test of 
normality indicated that the residuals of the model were normally distributed (p-value = 0.0572) and  the large W 
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= 0.935, is a good sign for normality. The ARCH-LM also indicated that the residuals were free from conditional 
heteroscedasticity (p-value = 0.6207). Hence the diagnostic test revealed that the model is adequate for 
prediction of FBS level. 
3.2.9 Profile test of Parallelism   
Multivariate Analysis of variance (MANOVA) was performed to complement and confirm the profile plot of test 
of parallelism as shown in Table 5. The MANOVA tests indicated that the profiles for the different levels of 
religion differed and are therefore not parallel. However, gender, marital status, drug and education did not 
significantly differ at the 5% significance level and therefore parallel, requiring test of parallelism.  
3.2.9.1 Test of Parallelism, Equality and Flatness for Gender group 
The Hotelling’s ; statistic for Gender is 2-group Hotelling’s  ;  = 13.424512 
		-			4	5	5<:	9,70 = > 80 − 9 − 180 − 2 × 9@ × 13.424512 = 1.3386265 
The hypothesis B8:	C-<	D.	DE	F-41	4.-	-GH4I	ED.		ℎ-		+D	Jgroups, was rejected at 5% significance level 
since  K.D > 9,70 = 0.2333 
The results of the tests for Parallelism, Equality and Flatness for Gender group are presented to Tables 6, 7 and 8 
respectively using a standard one-way MANOVA followed by a test that used a transformation of the dependent 
variables. Assuming homogeneity, at 5% level of significance, the results of the three tests confirmed that there 
is a significant change in FBS level of patients across the time points, and the pattern and level of change was the 
same for both sexes. 
3.2.9.2 Test of Parallelism, Equality and Flatness by Marital status 
The tests of parallelism, equality and flatness by marital status are given in tables 9, 10 and 11 respectively. 
The parallelism and equality test revealed that, the pattern of the average change in FBS level for the levels of 
marital status is not different and are approximately the same. The flatness, however, showed that the FBS level 
by marital status did not remain the same over time. 
3.2.9.3 Test of Parallelism, Equality and Flatness by Drug regimen 
The three tests are represented in tables 12, 13 and 14.  
At the 5% significant level, the parallelism and equality tests indicated that the difference in the pattern of 
change for the various types of drug is statistically insignificant. Thus the profiles of the average change in FBS 
level for the different types of drug is parallel and approximately the same. However, from the flatness test, we 
reject the null hypothesis that there is no change in FBS level, since the p-value (0.0000) is less than 0.05, 
indicating that the FBS level by drug changes over time.  
3.2.9.4 Test of Parallelism, Equality and Flatness by Educational level 
Tables 15, 16 and 17 presented the respective results for the three tests.  The parallelism and equality tests are 
not significant at 5% significance level, meaning that the profiles of the average change in FBS level for the 
different levels of education are approximately the same. Flatness test is significant, indicating that flatness is not 
proven and hence the mean FBS level does not remain the same over time  
 
4. Discussion 
The FBS level and other vital statistics of 80 diabetic patients on treatment were followed retrospectively 
through the study period of twenty-four months. The minimum age of the patients is 33years and the maximum 
age was 84years. The mean age is 58years and the median 53years with majority within the age group of 60-
69years, constituting 23.75% suggesting that aging increases the chances of having type 2 diabetes. The females 
(67.5%) were almost twice as the males (32.5%). The high number of females as compared to males may be due 
to the higher physical activity related energy expenditure in males compared to female subjects, hence lower rate 
of males living with type 2 diabetes  (Aspray et al., 2000). The lower rate in males may also be due to the usual 
unwillingness or lower rate at which males go for medical screening or test as compared to the females. The 
males and the females slightly differed in their average, as well as minimum and maximum FBS levels. Even 
though males were half of the females, the average FBS level of males (7.86196 mmol/l) is slightly higher than 
that of the females (7.52880mmol/l) which indicates that females seemed to better adhere to the treatment and 
management plans than the males or by genetic complement, FBS level progresses faster in males   (Table1). 
The similar initial increase and then decline in the pattern of change of FBS levels over time for both sexes is a 
direct indication that the treatment and management plans adopted to bring the situation  
under control were actually addressing the condition irrespective of gender even though performance is better in 
females than males. The test of parallelism, equality and flatness, showed that the pattern for both male and 
female patients is not only the same but also identical with the average FBS level changing over time. Thus 
while gender did not affect the change in FBS level, time did and that there is no time and group interaction 
(Tables 1, 6, 7 and 8).  
The educational pattern of profiles with consistent leading nature of the FBS level of the patients who had 
primary education indicated that their understanding of the basics of the condition is low, making them most 
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susceptible. However, the general pattern seemed to be approximately similar among the educational profiles. 
The result clearly indicates that high educated patients managed the condition better, perhaps they were able to 
understand the basic disease management and treatment plans better. 
The profiles for the effect of drug regimen on the change of FBS level showed that the three main drug 
regimens: metformin, glimepiride and glibenclamide seemed to have caused the change in FBS level over time, 
even though, the FBS level of patients on glibenclamide behaved a little strange as compared to the FBS level of 
patients on metformin and glimepiride (Figure 4). The profiles suggest that these drugs improved the condition 
of patients on treatment over time in corroboration of the finding by Garber et al (2006) that metformin-
glibenclamide treatment resulted in significantly greater reductions in HbA1C and FBS compared with 
metformin plus rosiglitazone in patients with type 2 diabetes. Zhu et at (2013) also suggested that metformin and 
glimepiride were not significantly different in glycaemic control of Type 2 Diabetes, suggesting that glimepiride 
would be a good choice second to metformin in the monotherapy of Type 2 Diabetes. These findings confirmed 
that the drugs in question are very effective in managing the condition.  
The profiling of the FBS level pattern of the different categories of marital status is also expressed and all the 
marital statuses follow almost the same trend with respect to time on treatment. This clearly shows that marital 
status is not a key indicator of the FBS level of the diabetic patients (Table 1, Figure 3).  
Although Christians lead in the religion profile, the profile did not show much difference (Figure 5). The 
MANOVA test of parallelism showed that there was significant differential in the pattern of change of the FBS 
level in religion, but gender, drug regimen, marital status, and educational level of the patients did not show any 
significant differentials in their pattern of change (Tables 5 to 17) 
The pattern of change in FBS level followed a cubic distribution (Table 2, Figure 6), indicating, initial increase 
and eventually falls. Thus while there is a consistent improvement in the FBS level of patients on treatment, this 
change decreases with time after having increased initially. This may be due to possible inconsistent use of the 
treatment and management plans or reduction in the efficacy of the treatment with time possibly by some 
intrinsic and extrinsic factors. The rate of change in FBS level is given by   = 0.267	 − 2.938	 +6.793 which can be used to estimate FBS level per unit time. The diagnoses of the cubic trend model further 
confirmed that this trend is significantly reliable for estimating the FBS level of patients on treatment (Tables 3 
and 4).  
 
5. Conclusion 
The Profile analysis of the retrospective data on FBS level of the 80 patients revealed cubic trend in the mean 
FBS level of patients on treatment, accounting for 91% of variability in the data. The MANOVA test of 
parallelism showed that religion was not parallel because there was significant differential in the pattern of 
change of the FBS level in religion. However, the other covariates: gender, marital status, drug and education did 
not significantly differ at the 5% significance level and hence their profiles were tested for parallelism. The 
parallelism tests revealed that they were parallel and equal but deviated from flatness. It is therefore concluded 
from the study that drug regimen, metformin, glimepiride and glibenclamide, are improving the condition. In 
addition to using the drugs, we suggest the use of the rate of change in FBS level function for monitoring and 
intervention of diabetic patients on the treatment. We further suggest for further research to test for the 
significant covariates for the type 2diabetes to fit mixed effect regression model (s) for monitoring patients on 
treatment. 
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APPENDIX 
Tables 
Table 1. Descriptive statistics of FBS level of patients on treatment 
Variables Percentage 
(%) 
Mean 
(fbs) 
Median 
(fbs) 
Min. 
(fbs) 
Max. 
(fbs) 
AGE (years) 
30-39 
40-49 
50-59 
60-69 
70-79 
80-89 
 
 
3.75 
20.00 
30.00 
23.75 
18.75 
3.75 
 
8.65556 
8.80486 
7.08935 
7.35263 
7.45925 
7.46296 
 
9.20000 
8.30000 
6.80000 
6.90000 
7.10000 
6.90000 
 
3.00000 
4.00000 
3.50000 
3.70000 
3.20000 
4.00000 
 
12.90000 
16.50000 
15.90000 
13.50000 
14.20000 
14.20000 
 
Mean      (Age) = 58 
Median     (Age) = 53 
Minimum  (Age) = 33 
Maximum  (Age) = 84 
GENDER 
Male 
Female 
 
 
32.50 
67.50 
 
7.86196 
7.52880 
 
7.40000 
7.10000 
 
3.00000 
3.20000 
 
16.50000 
16.40000 
EDUCATION 
Non 
Primary 
JHS 
SHS 
Tertiary 
 
20.00 
27.50 
25.00 
7.50 
20.00 
 
7.20347 
8.20555 
7.37666 
7.33888 
7.72638 
 
6.75000 
7.60000 
7.05000 
7.15000 
7.20000 
 
3.80000 
4.10000 
3.20000 
3.00000 
3.50000 
 
15.80000 
16.40000 
15.70000 
13.50000 
16.50000 
RELIGION 
Christian 
Islamic 
Traditional 
Other 
 
46.25 
16.25 
27.50 
10.00 
 
8.18918 
6.45982 
7.21161 
8.16666 
 
7.60000 
6.10000 
6.95000 
8.00000 
 
3.20000 
3.70000 
3.80000 
3.00000 
 
16.50000 
12.80000 
13.70000 
15.70000 
MARITATAL STATUS 
Married 
Single 
Separated 
Divorced 
Widow(er) 
 
57.50 
1.25 
10.00 
17.50 
13.75 
 
7.66135 
8.93333 
8.10138 
7.39444 
7.38888 
 
7.20000 
8.60000 
7.40000 
7.20000 
7.00000 
 
3.70000 
6.90000 
4.40000 
3.00000 
4.00000 
 
16.50000 
12.90000 
15.80000 
15.90000 
15.10000 
DRUG 
Metformin 
Glibenclamide 
Glimepiride 
 
46.25 
36.25 
17.50 
 
7.71051 
7.59540 
7.52936 
 
7.10000 
7.20000 
7.20000 
 
3.00000 
3.70000 
3.20000 
 
16.40000 
16.50000 
15.70000 
 
Table 2.Test of trend models 
Equation Model Summary Parameter Estimates 
R Square F df1 df2 Sig. b1 b2 b3 
Linear 
Logarithmic 
Inverse 
Quadratic 
Cubic 
Compound 
Power 
S 
Growth 
Exponential 
Logistic 
0.652 
0.693 
0.566 
0.853 
0.910** 
0.736 
0.771 
0.584 
0.736 
0.736 
0.736 
1347.957 
1623.218 
936.325 
2081.261 
2407.258 
2007.201 
2420.639 
1009.349 
2007.201 
2007.201 
2007.201 
1 
1 
1 
2 
3 
1 
1 
1 
1 
1 
1 
719 
719 
719 
718 
717 
719 
719 
719 
719 
719 
719 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
1.147 
4.221 
14.527 
3.629 
6.793 
1.359 
1.120 
0.307 
0.307 
0.307 
0.736 
 
 
 
 
-0.349 
-1.469 
 
 
 
 
 
0.089 
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Table 3. Analysis of Variance for Cubic trend model 
ANOVA 
Source SS DF MS F Sig. 
Regression 512.393 3 170.798 35.009 .000 
Residual 3493.105 716 4.879   
Total 4005.499 719    
 
Table 4. Trend model Diagnoses 
  P-value 
Shapiro-Wilks W = 0.935 0.0572 
ARCH-LM Chi-Sq.= 3 0.6207 
 
Table 5. MANOVA Test for Groups 
Source  Statistic Df F(df1 df2) F Prob>F 
 
Gender 
 
W 
P 
L 
R 
 
0.9923 
0.0077 
0.0078 
0.0078 
 
1 
 
1.0 
1.0 
1.0 
1.0 
 
65.0 
65.0 
65.0 
65.0 
 
1.50 
1.50 
1.50 
1.50 
 
0.4804 e 
0.4804 e 
0.4804 e 
0.4804 e 
 
Marital 
Status 
 
W 
P 
L 
R 
 
0.9216 
0.0784 
0.0851 
0.0851 
 
4 
 
4.0 
4.0 
4.0 
4.0 
 
65.0 
65.0 
65.0 
65.0 
 
1.38 
1.38 
1.38 
1.38 
 
0.2495 e 
0.2495 e 
0.2495 e 
0.2495 e 
 
Religion 
 
W 
P 
L 
R 
 
0.8547 
0.1453 
0.1701 
0.1701 
 
3 
 
3.0 
3.0 
3.0 
3.0 
 
65.0 
65.0 
65.0 
65.0 
 
3.68 
3.68 
3.68 
3.68 
 
0.0163 e 
0.0163 e 
0.0163 e 
0.0163 e 
 
Drug 
 
W 
P 
L 
R 
 
0.9873 
0.0127 
0.0129 
0.0129 
 
2 
 
2.0 
2.0 
2.0 
2.0 
 
65.0 
65.0 
65.0 
65.0 
 
0.42 
0.42 
0.42 
0.42 
 
0.6602 e 
0.6602 e 
0.6602 e 
0.6602 e 
 
Education 
 
W 
P 
L 
R 
 
0.9623 
0.0377 
0.0391 
0.0391 
 
4 
 
4.0 
4.0 
4.0 
4.0 
 
65.0 
65.0 
65.0 
65.0 
 
0.64 
0.64 
0.64 
0.64 
 
0.6387 e 
0.6387 e 
0.6387 e 
0.6387 e 
 
Residual 
   
65 
    
 
Total 
   
79 
    
 
W = Wilks' lambda L = Lawley-Hotelling trace P = Pillai's trace R = Roy's largest root 
e = exact, a = approximate, u = upper bound on F 
 
Table 6. Multivariate test of parallelism by Gender 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.8543 
0.1457 
0.1706 
0.1706 
1 8.0 
8.0 
8.0 
8.0 
71.0 
71.0 
71.0 
71.0 
1.51 
1.51 
1.51 
1.51 
0.1677 e 
0.1677 e 
0.1677 e 
0.1677 e 
Residual   78     
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Table 7: Test of Equality in Gender. 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.9906 
0.0094 
0.0095 
0.0095 
 
1 1.0 
1.0 
1.0 
1.0 
78.0 
78.0 
78.0 
78.0 
0.74 
0.74 
0.74 
0.74 
0.3917 e 
0.3917 e 
0.3917 e 
0.3917 e 
 
Residual   78     
 
Table 8. Multivariate Test of flatness by Gender 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.3466 
0.6534 
1.8850 
1.8850 
 
1 8.0 
8.0 
8.0 
8.0 
71.0 
71.0 
71.0 
71.0 
16.73 
16.73 
16.73 
16.73 
0.0000 e 
0.0000 e 
0.0000 e 
0.0000 e 
Residual   78     
W = Wilks' lambda L = Lawley-Hotelling trace P = Pillai's trace R = Roy's largest root 
 
Table 9. Test of parallelism by marital status 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.7050 
0.3279 
0.3734 
0.1965 
4 32.0 
32.0 
32.0 
8.0 
252.4 
284.0 
266.0 
71.0 
0.78 
0.79 
0.78 
1.74 
0.7931 a 
0.7829 a 
0.8037 a 
0.1031 u 
Residual   75     
Table 10. Test of level (Equality) by marital status 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.9760 
0.0240 
0.0246 
0.0246 
4 4.0 
4.0 
4.0 
4.0 
75.0 
75.0 
75.0 
75.0 
0.46 
0.46 
0.46 
0.46 
0.7635 e 
0.7635 e 
0.7635 e 
0.7635 e 
Residual   75     
W = Wilks' lambda L = Lawley-Hotelling trace P = Pillai's trace R = Roy's largest root 
e = exact, a = approximate, u = upper bound on F 
 
Table 11. Test of flatness by marital status 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.6482 
0.3518 
0.5428 
0.5428 
1 8.0 
8.0 
8.0 
8.0 
68.0 
68.0 
68.0 
68.0 
4.61 
4.61 
4.61 
4.61 
0.0002 e 
0.0002 e 
0.0002 e 
0.0002 e 
esidual   75     
W = Wilks' lambda L = Lawley-Hotelling trace P = Pillai's trace R = Roy's largest root 
e = exact, a = approximate, u = upper bound on F 
 
Table 12. Test of Parallelism by drug  
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.8359 
0.1701 
0.1892 
0.1368 
2 16.0 
16.0 
16.0 
8.0 
140.0 
142.0 
138.0 
71.0 
0.82 
0.83 
0.82 
1.21 
0.6606 e 
0.6556 a 
0.6659 a 
0.3035 u 
Residual   77     
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Table 13. Test of Level (Equality) for drug 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.9980 
0.0020 
0.0020 
0.0020 
 
2 2.0 
2.0 
2.0 
2.0 
77.0 
77.0 
77.0 
77.0 
0.08 
0.08 
0.08 
0.08 
0.9263 e 
0.9263 e 
0.9263 e 
0.9263 e 
Residual   77     
 
Table 14. Test of Flatness by drug. 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.3613 
0.6387 
0.7676 
0.7676 
 
1 8.0 
8.0 
8.0 
8.0 
70.0 
70.0 
70.0 
70.0 
15.47 
15.47 
15.47 
15.47 
 
0.0000 e 
0.0000 e 
0.0000 e 
0.0000 e 
Residual   77     
 
 
Table 15. Test of Parallelism by Educational level 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.6547 
0.3951 
0.4555 
0.2220 
 
4 32.0 
32.0 
32.0 
8.0 
252.4 
284.0 
266.0 
71.0 
0.96 
0.97 
0.95 
1.97 
 
0.5333 a 
0.5135 a 
0.5539 a 
0.0627 u 
Residual   75     
 
 
Table 16. Test of Level by Educational level. 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.9407 
0.0593 
0.0630 
0.0630 
 
4 4.0 
4.0 
4.0 
4.0 
75.0 
75.0 
75.0 
75.0 
1.18 
1.18 
1.18 
1.18 
 
0.3259 e 
0.3259 e 
0.3259 e 
0.3259 e 
Residual   75     
 
 
Table 17. Test of Flatness by Educational level. 
Source  Statistic Df F(df1 df2) F Prob>F 
 W 
P 
L 
R 
0.3685 
0.6315 
1.7138 
1.7138 
 
1 8.0 
8.0 
8.0 
8.0 
68.0 
68.0 
68.0 
68.0 
14.57 
14.57 
14.57 
14.57 
 
0.0000 e 
0.0000 e 
0.0000 e 
0.0000 e 
Residual   75     
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 Figures 
 
 
Figure 1. Profile plot of FBS level by gender 
 
 
 
Figure 2. Profile plots of FBS level by Educational level. 
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Figure 3. Profile plots of FBS level by marital status. 
 
 
 
Figure 4. Profile plot of FBS level by drug 
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Figure 5. Profile plots of Fasting Blood Sugar Level by Religion. 
 
 
Figure 6. Profile plot of FBS level depicting cubic pattern 
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